BCG Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting bcg clinical trials across 6 countries. Studies span Phase 2, Phase 3, Not Applicable, Phase 4. Top locations include Bissau, Bissau Codex, Guinea-Bissau, Chicago, Illinois, United States, Fuzhou, Fujian, China. Updated daily from ClinicalTrials.gov.


BCG Trials at a Glance

7 actively recruiting trials for bcg are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Bissau, Chicago, and Fuzhou. Lead sponsors running bcg studies include BLAD-HYA Group, Bandim Health Project, and Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd..

Browse bcg trials by phase

Treatments under study

About BCG Clinical Trials

Looking for clinical trials for BCG? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new BCG trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about BCG clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Urothelial CarcinomaBladder CancerNon-Muscle-Invasive Bladder Cancer (NMIBC)+8 more
Michael A. O'Donnell174 enrolled1 locationNCT07322263
Recruiting
Not Applicable

Early vs Delayed Intravesical Blad-Care During BCG Therapy

Urinary Bladder NeoplasmsBCG-Induced Cystitis
BLAD-HYA Group56 enrolled1 locationNCT07495072
Recruiting
Phase 3

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

BCG
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.438 enrolled1 locationNCT06747455
Recruiting
Phase 2

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc.90 enrolled16 locationsNCT03945162
Recruiting
Phase 3

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Urinary Bladder NeoplasmsTreatment OutcomeImmunotherapy, Active+3 more
Fujian Medical University Union Hospital76 enrolled1 locationNCT06441110
Recruiting
Phase 4

Measles and BCG Vaccines for Mother and Child

Mother-Infant InteractionMeaslesVaccine Preventable Disease+1 more
Bandim Health Project2,400 enrolled1 locationNCT04899765
Recruiting

Bacille Calmette-Guérin (BCG) Immune Response Study

Immune response after BCG vaccineTuberculosis
The Mercy Hospital for Women256 enrolled1 locationACTRN12608000227392